Welcome
/pharmacy/Connect With Us
Resources and Links
- Assessment
- Blackboard/WebCT Login
- College Catalog
- Career Series Bulletin
- Commencement
- Drug Information Resources
- Experiential Education
- Honors Program
- Library/Learning Resources
- Research Opportunities for CPPS Students
- Student Affairs
- Student Organizations
Contact Us
Health Science Campus
Frederic and Mary Wolfe Center
Room 141
Phone: 419.383.1566
Fax: 419.383.1950
Information
- Pharmacy Practice
- Teaching
- Patient Care
- Department Research
- Faculty and Staff
- Continuing Education
- Important Links
- Industrial Pharmacy
- Health Outcomes and Socioeconomic Sciences
- Department Highlights
- Department Publications
- Department Abstracts and Presentations
- Department Service Activity
- Profession Leadership
Laurie S. Mauro, Pharm.D.
|
Assistant Dean of Academic Affairs 419.383.1953 |
|
Dr. Mauro earned her B.S. in Pharmacy from Ohio Northern University and her Doctor of Pharmacy from The Ohio State University. She completed a Clinical Pharmacy Practice Residency at the University of Illinois at Chicago. She is also Adjunct Associate Professor of Medicine in the College of Medicine, University of Toledo.
Dr. Mauro teaches Drug Information and coordinates Drug Information instruction that is integrated into 6 laboratory courses over 3 years of the Doctor of Pharmacy curriculum. She also coordinates and lectures in Pathophysiology and Pharmacotherapy - Poison Management. She also lectures in a number of areas of pathophysiology and pharmacotherapeutics including Renal, and Cardiology. She maintains a clinical practice with the Medical Intensive Care Team at the University of Toledo Medical Center where she precepts a critical care rotation.
Dr. Mauro is currently Director of Educational Assessment for the College of Pharmacy, Chair of the Assessment Committee and Chair of the Curricular Evaluation Subcommittee. She serves on the Academic Performance Committee, and Professional Conduct Committee. She serves on the Critical Care Editorial Panel of Annals of Pharmacotherapy. She is a member of American Association of Colleges of Pharmacy, American College of Clinical Pharmacy, American Society of Health Systems Pharmacists, and Society of Critical Care Medicine.
Refereed Original Research
1. Mauro LS, Mauro VF, Brown DL, Somani P: Enhancement of phenytoin elimination by multiple dose activated charcoal. Ann Emerg Med. 1987; 16:1132-1135.
2. Brown DL, Mauro LS: Vancomycin dosing chart for use in patients with renal impairment. Am J Kidney Dis. 1988; 11:15-19.
3.Mauro VF, Mauro LS, Hageman VF: Alteration of pentoxifylline pharmacokinetics by cimetidine. J Clin Pharmacol. 1988; 28; 649-54.
4. Mauro LS, Mauro VF, Bachmann KA, Higgins JT: Accuracy of two equations at determining normalized phenytoin concentrations. DICP 1989; 23:64-8.
5. Mauro LS, Mauro VF, Miller PL, Lacher DA:Effect of cefotetan on creatinine determination by the picric acid and enzymatic methods.Clin Pharm.1989; 8:505-8.
6. Mauro LS, Mauro VF. Effect of serum separator tubes on serum quinidine concentration measurements. Clin. Pharm. 1990; 9:292-294.
7. Mauro VF, Mauro LS, Fraker TD, Temesy-Armos PN, Somani P. Effect of aluminum hydroxide gel on quinidine gluconate absorption. DICP 1990; 24:252-254.
8. Mauro LS, Mauro VF. Effect of serum separator tubes on free and total phenytoin and carbamazepine concentrations. Ther Drug Monit. 1991; 13:240-43.
9. Bachmann K, Sullivan TJ, Mauro LS, Martin M, Juaregui L, Levine L. Comparative investigation of the influence of nizatidine, ranitidine, and cimetidine on the steady-state pharmacokinetics of theophylline in COPD patients. J Clin Pharmacol. 1992; 32:476.
10. Mauro VF, Mauro LS, Hageman JH. Comparison of pentoxifylline pharmacokinetics between smokers and nonsmokers. J Clin Pharmacol. 1993; 32:1054-58.
11. Wolff D, Kline S, Mauro LS. Stability of amikacin, gentamicin or tobramycin in
10%
dextrose. Am J Hosp Pharm. 1994; 51:518-19.
12. Mauro VF, Mauro LS, Klions HK. Effect of single dose fluoxetine on theophylline serum concentrations. Am J Ther. 1994; 1:304-8.
13. Mauro VF, Jacobs LR, Mauro LS, MacArthur RD, White DB. Comparison of tobramycin pharmacokinetics after administration by CRIS and a traditional intravenous piggyback infusion. Ann Pharmacother. 1995; 29:465-9.
14. Mauro LS, Kuhl DA, Kirchhoff JR, Mauro VF, Hamilton RW. Effect of oral bases on aluminum absorption. Am J Ther 2001; 8: 21-25.
15. Mauro VF, Mauro LS, Kleshinski JF, Erhardt PW. Impact of Ginkgo Biloba on pharmacokinetics of digoxin. Am J Ther 2003; 10: 247-251.
16. Peeters MJ, Churchwell MD, Mauro LS, Cappelletty DM, Stone GE. A student-inclusive pharmacotherapeutic textbook selection process. Currents in Pharmacy Teaching & Learning 2010:2(1):31-38.
Refereed Clinical Reviews
1. Kline S, Mauro LS: Deferoxamine therapy of iron overload in chronic dialysis patients. In: Conner C, Rumack BH, eds. Drugdex Information System, Denver, CO: Micromedex, Inc. 1986.
2. Mauro VF, Mauro LS: Use of intermittent dobutamine infusion in congestive heart failure. Drug Intell Clin Pharm. 1986; 20:919-24.
3. Mauro LS, Kline SS: Treatment of atrial fibrillation after digoxin immune Fab administration. Hospital Therapy. 1987; 12:55-61.
4. Dunsworth TS, Mauro LS: Prevention of Amphotericin B induced nephrotoxicity with mannitol. Drug Intell Clin Pharm. 1988; 22:327-328.
5. Keith RL, Mauro LS, Mauro VF: Beta blocking alternatives in essential tremor. Drug Intell Clin Pharm. 1988; 22:613-14.
6. Mauro VF, Mauro LS, Kepler L. Digoxin-diltiazem drug interaction. In: Conner CS, Rumack BH, eds. Drugdex Information System, Denver, CO: Micromedex, Inc., 1992.
7. Mauro VF, Mauro LS: Pathophysiology and pharmacotherapy of angina pectoris. Clin Trends Hosp Pharm. 1990; 4:45-56.
8. Mauro VF, Mauro LS. Pathophysiology and pharmacotherapy of Parkinson's Disease - Part I. Clin Trends Hosp Pharm. 1993; 7:1-4.
9. Mauro VF, Mauro LS. Pathophysiology and pharmacotherapy of Parkinson's Disease - Part II. Clin Trends Hosp Pharm. 1993; 7:13-20.
10. Kuhl D, Agiri K, Mauro LS. Bronchodilators for the treatment of acute exacerbation of chronic obstructive pulmonary disease. Ann Pharmacother 1994; 28:1379-88.
11. Mauro LS, Nawarskas J, Mauro VF. Misadventures with multiple dose activated charcoal. Ann Pharmacother. 1994; 28:915-24.
12. Frazee L, Mauro LS. Erythromycin for diabetic gastroparesis. Am J Ther 1994; 1:287-95.
13. Mauro LS, Borovicka MW, Kline SS. An introduction to coronary artery stents and their pharmacotherapeutic management. Ann Pharmacother 1997; 31:1490-98.
14. Herner SL, Mauro LS. Epoprostenal for primary pulmonary hypertension. Ann Pharmacother 1999; 33:340-347.
15. Barcelona I, Mauro LS. Selective Serotonin reuptake inhibitors in premenstrual dysphoric disorder. J Pharm Technol 2001; 17: 131-9.
16. Mauro LS, Alexander K. Compatibility of Critical Care Admixtures. Hosp Pharm, 2005; 40: Wall chart.
17. Beach MA, Mauro LS. Pharmacotherapeutic expulsive therapy of ureteral calculi. Ann Pharmacother 2006;40:1361-8.
18. Losek RL, Mauro, LS. Efficacy of tamsulosin with extracorporeal shock Wave lithotripsy for passage of renal and ureteral calculi, Ann. Pharmacother 2008;42:692-697.
19. Sawyer E, Mauro LS, Ohlinger MJ. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann. Pharmacother 2008;42:247-252.
20. Mauro LS. Compatibility of Critical Care Admixtures. Hosp Pharm, Wall chart, in press
Refereed Journals - Brief Notes
1. Simkover R, Mauro, LS: The effect of clonidine on cerebral blood flow. In: Conner CS, Rumack BH, eds. Drugdex Information System, Denver, CO: Micromedex, Inc. 1986.
2. Mauro LS: Diptheria-pertussis-tetanus vaccine and sudden infant death syndrome. Drug Intell Clin Pharm. 1986; 20:672-3.
3. Mauro LS: Ritodrine-propranolol interaction. In: Conner CS, Rumack BH, eds - Drugdex Information System, Denver, Co: Micromedex, Inc. 1986.
4. Mauro LS, Bonfiglio MF: Hyperammonemia and encephalopathy caused by essential amino acid administration. Drug Intell Clin Pharm. 1987; 21:970-971.
5. Mauro LS, Brown DL, Goetting M: The use of sucralfate for the prevention of stress ulcers. Drug Intell Clin Pharm. 1987; 21:711-712.
6. Mauro LS, Dunsworth TS: Estrogens and risk of thromboembolism in post menopausal women. In: Conner CS, Rumack BH, eds. Drugdex Information System, Denver, CO: Micromedex, Inc., 1987.
7. Mauro LS, Miller PC, Lacher DA, Mauro VF, Hicks CI: Effect of cefotetan on serum and urine creatinine determination. (Abstract) Pharmacotherapy. 1988; 8:124.
8. Mauro LS: Multiple dose activated charcoal: an ever expanding role. Ann Emerg Med. 1988; 17:1134-8. Letter In Reply.
9. Mauro VF, Mauro LS, Kepler L. Digoxin-Diltiazem Drug Interaction. Drugex: Drug Consult; Micromedex: Vol 70: 1991.
10. Mauro LS, Mauro VF, Bachmann KA: Comment: phenytoin equation accuracy. Anna Pharmacother. 1989; 23:621-22. Author's Reply to Letter to the Editor.
11. Mauro VF, Mauro LS. Applied Therapeutics; 5th ed (Book Review) Clin Pharm. 1992; 11:897-900.
12. Mauro LS, Kuhl DA, Kirchhoff JR, Mauro VM. Effect of oral bases on aluminum absorption (Abstract) Pharmacotherapy 1995; 15:107-8.
13. Waller C, Mauro LS. Amantadine for patients with brain injury. In: Conner CS,
Rumack BH, eds. Drugdex Information System, Denver, CO: Micromedex, Inc. 1997.
14. Mauro LS, Wissuchek J, Wong F, Thompson G. Surgical considerations in Jehovah's
Witnesses. In: Conner CS, Rumack BH, eds. Drugdex Information System, Denver, CO:
Micromedex Healthcare Services, Inc. 1999, Vol 102.
15. Grimm A, Kendell JD, Mauro LS, Stringer K, Turco TF. Erythropoeitin drug evaluation:
Anemia-traumatic postsurgical. In: Conner CS, Rumack BH, eds. Drugdex Information
System, Denver, CO: Micromedex Healthcare Services, Inc. 1999, Vol 102.
16. Wissuchek JA, Mauro LS, Evans RP, Johnson O. Haloperidol intravenous use. Drug
Consult. In: Conner CS, Rumack BH, eds. Drugdex Information System, Denver, CO:
Micromedex Healthcare Services, Inc. 1999, Vol 102.
17. Mauro LS, Wanke LA. Haloperidol Drug Evaluation: Intravenous Dosing. In: Conner CS, Rumack BH, eds. Drugdex Information System, Denver, CO: Micromedex Healthcare Services, Inc. 1999, Vol 102.
18. Kier KL, Mauro LS. Cooperative faculty development of a web-based drug information course for a non-traditional Pharm.D. program. Am J Pharm Ed 1998; 62 Winter Supp 100S.
19. Kier KL, Mauro LS. Cooperative faculty development of a web-based drug information certificate program for pharmacists. Am J Pharm Ed 1999, 63 Winter Supp, 88S.
20. Mauro VF, Mauro LS, Kleshinski JF, Erhardt PW. Impact of Ginkgo Biloba on the pharmacokinetics of digoxin (abstract). Pharmacotherapy 2001; 21:373.
21 Mauro LS, McCall, L, Kamm GL, Gilis AP, Black CD. Integration of Drug information skills into a professional practice development course series. (Abstract) Am J Pharm Ed 2001; 65: 104S.
22. Mauro LS. E-pharmacy: A guide to the Internet Care Zone. (book review) Am J Pharm Ed 2002; 66: 341-2.
23. Mauro LS, Assaly R, Shereif I, Malhotra D. Determination of linezolid clearance via hemodiafiltration. (Abstract) Pharmacotherapy 2001
24. Mauro LS. Stockley's Drug Interactions, 2nd edition. Book Review. Am J Pharm Ed 2003; 67: Article 72.
25. Powers MF, Mauro LS Providing PDA classroom demonstration using handheld screen display software with an expansion device in a professional practice development course. (Abstract) Am J Pharm Ed 2003; 67: Article 100: 17.
26. Abbott GV, Mauro VF, Mauro LS. Pearls to prevent pharmacy perils: Use of magnesium in renal failure. Ohio Pharmacist 2003; 52 (July): 18-19.
27. Mauro LS, Powers MF. Enabling students for decision-making regarding handheld drug information software through a laboratory exercise. (Abstract) Am J Pharm Ed 2004, 68: Article 54, 45
28. Mauro LS. Clinical Pharmacokinetics. Book Review. Ann Pharmacother 2006;40: 1893.
Refereed Journals - Case Reports
1. Kline SS, Mauro LS, Scala-Barnett DM, Zick D. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Clin Pharm. 1989; 8:510-14.
2. Hagmeyer KO, Mauro LS, Mauro VF. Meperidine use related seizures associated with patient controlled analgesia pumps. Ann Pharmacother. 1993; 27:29-32.
3. Mauro LS, Peloquin CA, Schmude K, Assaly R, Malhotra D. Clearance of linezolid via continuous venovenous hemodiafiltraton: a case report. Am J Kid Dis 2006 Jun;47(6):e83-6.
BOOK CHAPTERS
1. Mauro LS. Chronic Renal Failure In: Donnelly AF, Baughman VL, Gonzales JP, Tomsik EA, editors. Anesthesiology and Critical Care Drug Handbook. 6th Ed. Hudson, Ohio LexiComp, 2005. p. 1272-1276.
2. Mauro LS. Continuous Renal Replacement Therapy. In: Donnelly AF, Baughman VL, Gonzales JP, Tomsik EA, editors. Anesthesiology and Critical Care Drug Handbook. 6th Ed. Hudson, Ohio LexiComp, 2005. p. 1282-1285.
3. Mauro LS. Chronic Renal Failure In: Donnelly AF, Baughman VL, Gonzales JP, Tomsik EA, editors. Anesthesiology and Critical Care Drug Handbook. 7th Ed. Hudson, Ohio, LexiComp, 2007. p.1437-41.
4. Mauro LS. Continuous Renal Replacement Therapy. In: Donnelly AF, Baughman VL, Gonzales JP, Tomsik EA, editors. Anesthesiology and Critical Care Drug Handbook. 7th Ed., Hudson, Ohio LexiComp, 2007. p. 1447-1450.
5. Mauro LS. Chronic Renal Failure In: Donnelly AF, Baughman VL, Gonzales JP, Golembiewski J, Tomsik EA, editors. Anesthesiology and Critical Care Drug Handbook. 8th Ed. Hudson, Ohio, LexiComp, 2008. p.1445-49.
6. Mauro LS. Continuous Renal Replacement Therapy. In: Donnelly AF, Baughman VL, Gonzales JP, Golilembiewski J, Tomsik EA, editors. Anesthesiology and Critical Care Drug Handbook. 8th Ed., Hudson, Ohio LexiComp, 2008. p. 1455-1458.
7. Mauro LS, Losek RL. The role of medical expulsive therapy for treatment of ureteral calculi, book chapter in "Aspects of pharmacology of the pyeloureter with clinical perspectives", Research Signpost, 2009.
8. Mauro LS. Chronic Renal Failure In: Donnelly AF, Baughman VL, Gonzales JP, Golembiewski J, Tomsik EA, editors. Anesthesiology and Critical Care Drug Handbook. 8th Ed. Hudson, Ohio, LexiComp, 2009. p.1445-49.
9. Mauro LS. Continuous Renal Replacement Therapy. In: Donnelly AF, Baughman VL, Gonzales JP, Golilembiewski J, Tomsik EA, editors. Anesthesiology and Critical Care Drug Handbook. 8th Ed., Hudson, Ohio LexiComp, 2009. p. 1455-1458.
10. Mauro LS. Chronic Renal Failure In: Donnelly AF, Baughman VL, Gonzales JP, Golembiewski J, Tomsik EA, editors. Anesthesiology and Critical Care Drug Handbook. 9th Ed. Hudson, Ohio, LexiComp, 2010, in press.
11. Mauro LS. Continuous Renal Replacement Therapy. In: Donnelly AF, Baughman VL, Gonzales JP, Golilembiewski J, Tomsik EA, editors. Anesthesiology and Critical Care Drug Handbook. 9th Ed., Hudson, Ohio LexiComp, 2010., in press.
POSTERS
1. V. F. Mauro, L. S. Mauro, J.H. Hageman. Alteration of pentoxifylline pharmacokinetics by cimetidine. 1987 OCCPCP Annual Meeting, Toledo, Ohio.
2. L. S. Mauro, V F. Mauro, D. L. Brown, P. Somani. Enhancement of phenytoin elimination with multiple dose activated charcoal. 1987 OCCPCP Annual Meeting, Toledo, Ohio.
3. Laurie S. Mauro, Phillip C. Miller, David A. Lacher, Vincent F. Mauro, Charles I. Hicks. Effect of cefotetan on serum and urine creatinine determination. 1988 ACCP Meeting, Philadelphia, Pennsylvania.
4. D. Wolfe, S.S. Kline, L.S. Mauro, Stability of amikacin, gentamicin, tobramycin, and vancomycin in 10% dextrose. 1989 ASHP Midyear Clinical Meeting.
5. V.F. Mauro, L.. Mauro, T. Fraker, P.N. Temesy-Armos, P. Somani. Effect of aluminum hydroxide on quinidine gluconate absorption. 1989 OCCPCP Annual Meeting Columbus, Ohio.
6. L.S. Mauro, V.F. Mauro, Effect of serum separator tubes on serum quinidine concentrations. 1989 OCCPCP Annual Meeting, Columbus, Ohio.
7. L.S. Mauro, V.F. Mauro, Effect of serum separator tubes on serum phenytoin concentration. 1990 OCCPCP Annual Meeting, Dellroy, Ohio.
8. L.S. Mauro, V.F. Mauro, Effect of serum separator tubes on phenytoin and carbamazepine concentration. February 1991. ACCP Research Forum, Ft. Lauderdale.
9. V.F. Mauro, L.S. Mauro, Effect of smoking on pentoxifylline clearance. 1991 OCCPCP Annual Meeting, Toledo, Ohio.
10. K Bachmann, T.J. Sullivan, L.S.Mauro, M. Martin, L.Juaregui, L. Levine. Comparative investigation of the influence of nizatidine, ranitidine, and cimetidine on the steady-state pharmacokinetics of theophylline in COPD patients. 1991 OCCPCP Annual Meeting, Toledo, Ohio.
11. V.F. Mauro, L.S. Mauro, H.H. Klions. Effect of single dose fluoxetine on aminophylline pharmacokinetics. 1994 ACCP Meeting, St. Louis, Missouri.
12. L.S. Mauro, D.A. Kuhl, J. R. Kirchhoff, V.F. Mauro, R.W. Hamilton. Effect of oral bases on aluminum absorption, 1995 ACCP Winter Practice and Reserve Forum, Orlando, Florida.
13. K.L. Kier, L.S. Mauro. Cooperative faculty development of a web-based Drug Information course for a non-traditional Doctor of Pharmacy Program. 1998 AACP Annual Meeting, Aspen, Colorado, July 1998.
14. K. Kier, L.S. Mauro, A. Escovitz , C. Green . Cooperative faculty development of a web-based Drug Information Certificate Program for pharmacists. 1999 AACP Annual Meeting, Boston, Massachusetts, July 1999.
15. C.L. Ahrens, L.S. Mauro, V. F. Mauro. Evaluation of a weight-based heparin dosing protocol in obesity. December 2000, ASHP Midyear Clinical Meeting, Las Vegas, NV.
16. V.F. Mauro, L.S. Mauro, J.F. Kleshinski, P.W. Erhardt. Impact of Gingko Biloba on the pharmacokinetics of digoxin. 2001 ACCP Spring Research Forum, Salt Lake City, Utah.
17. Mauro L.S., McCall L, G.L. Kamm , A. P. Gilis, C.D. Black. Integration of basic drug Drug Information skills into a professional development course series. July 2001 American Association of Colleges of Pharmacy, Toronto.
18. Mauro L.S., Assaly R., Shareif I., Malhotra D. Determination of linezolid clearance via hemodiafiltration. American College of Clinical Pharmacy, October 2001, St Petersburg FL.
19. Powers M.F., Mauro L.S. Providing PDA classroom demonstration using handheld screen display software with an expansion device in a professional practice development course. AACP Annual Meeting, Minneapolis, MN, July 2003
20. Mauro L.S., Powers M.F. Enabling students for decision-making regarding handheld drug information software through a laboratory exercise. AACP Annual Meeting, Salt Lake City, Utah, July 2004.
21. Mauro LS, Schmude KA, Black CD. Competency development in pharmacotherapeutic planning through SOAP cases. School Poster Presentation, AACP Annual Meeting, Lake Buena Vista, Florida, July 2007.
22. Peeters MJ, Churchwell MD, Mauro LS, Cappelletty DM, Stone GE. A Rasch-based pharmacotherapeutics textbook selection methodology, AACP Annual Meeting, Chicago, IL, July 2008.
PLATFORM PRESENTATIONS
1. Mauro V.F., Mauro L.S., Klions H.H. Effect of single dose fluoxetine on theophylline serum concentrations. 1995 OCCPCP Annual Meeting, Cleveland, Ohio.
2. Escovitz A., Kier K., Mauro L. Using distance education to deliver a Drug Information Certificate Program: Administration issues, teaching experiences, and student orientation. 1999 Annual AACP Meeting, Boston, Massachusetts, July 1999.
3. Kier K., Mauro L. Cooperative faculty development and delivery of a web-based Drug Information Certificate Program. 1999 Annual ASHP Midyear Clinical Meeting, Orlando, Florida.
UT Virtual View Book
UT Rockets
A University Rising
UTMC Named Regions #1 Hospital
